# Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment

> **NCT04053699** · — · COMPLETED · sponsor: **Octapharma** · enrollment: 56 (actual)

## Conditions studied

- Von Willebrand Diseases

## Interventions

- **DRUG:** Von Willebrand Factor-Containing Product

## Key facts

- **NCT ID:** NCT04053699
- **Lead sponsor:** Octapharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-25
- **Primary completion:** 2021-01-31
- **Final completion:** 2021-01-31
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2023-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04053699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04053699, "Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04053699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*